Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $94.2100 (1.04%) ($91.2400 - $96.7100) on Thu. Sep. 24, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.26% (three month average) | RSI | 39 | Latest Price | $94.2100(1.04%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | LGND declines -4.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(50%) IWM(48%) IWC(47%) | Factors Impacting LGND price | LGND will decline at least -1.13% in a week (0% probabilities). VIXM(-21%) UUP(-16%) VXX(-14%) IGOV(-7%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.13% (StdDev 2.26%) | Hourly BBV | 0.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $85.43(-9.32%) | Inflection Point | Yes | Resistance Level | $97.56 | 5 Day Moving Average | $91.78(2.65%) | 10 Day Moving Average | $94.28(-0.07%) | 20 Day Moving Average | $97.56(-3.43%) | To recent high | -25.7% | To recent low | 5.2% | Market Cap | $1.514b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |